News
Discover the latest news and developments in AI and machine learning happening in the image-guided therapy (IGT) sector in Canada.
From Risk to Hyper-Precision: How ViTAA Medical is leveraging imaging and AI to redefine Aortic Aneurysm Care
Using AI-assisted 3D modelling, ViTAA Medical is determined to bring aneurysm management into the 21st century. For the last 15 years, Dr. Elena Di Martino, a biomedical engineer and Dr. Randy Moore, a vascular surgeon (both teach at the University of Calgary), have been perfecting technology that uses computer algorithms to analyze information gathered on a CT scan to create 3D models of aneurysms that encode the actual mechanical properties of the vessel’s wall.
INOVAIT opens Pilot Fund program to support Canadian image-guided therapy and artificial intelligence projects
INOVAIT, the Canadian image-guided therapy (IGT) and AI network, is opening a call for applications for its Pilot Fund. The INOVAIT Pilot Fund is a reimbursement-based funding program to support collaborative research and development (R&D) projects that apply artificial intelligence, machine learning, or big data to IGT technologies.
A trailblazer in medical imaging: Terry Peters
Network News
INOVAIT awards two leading companies and one academic partner for transforming Canada’s healthcare ecosystem
TORONTO, April 25, 2024 /CNW/ - INOVAIT, the national network for commercializing breakthroughs in image-guided...
2024 Discovery Forum Recap
Last week, we hosted our 3rd annual Discovery Forum and welcomed our esteemed members from across the country to Torys...
Tenomix secures oversubscribed $2.1M, all-Canadian financing round to advance cancer staging
Tenomix, an image-guided diagnostic company based out of Western University’s BioNext Medtech Incubator, recently celebrated a significant milestone with an oversubscribed all-Canadian $2.14M funding round. Established in 2021 by four alums of WORLDiscoveries’ Medical Innovation Fellowship program at Western University, Tenomix is transforming cancer staging, particularly in colorectal cancer, with its innovative approach.
PulseMedica is laser-focused on tackling vitreoretinal diseases
The PulseMedica platform is a 3D image-guided therapy device that integrates powerful laser therapy, advanced medical imaging, and limitless machine learning (ML) for precision imaging and treatment of vitreoretinal disease. Vitreoretinal diseases exist within the clear gel (vitreous fluid) that fills the eye and retina at the back of the eye. PulseMedica’s device strives to automate the imaging and treatment process, enabling quick and precise disease targeting, thereby reducing the treatment time and reducing the risk of side effects and total time per patient, allowing for more patients to be treated each day.
IGT Lecture Series
Regulating AI in Image-Guided Therapy
Follow INOVAIT on Social Media
The Network in the Press
